Pages that link to "Q42967326"
Jump to navigation
Jump to search
The following pages link to Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants (Q42967326):
Displaying 15 items.
- Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24195000) (← links)
- Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24200642) (← links)
- Enteral iron supplementation in preterm and low birth weight infants (Q24201113) (← links)
- Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24245418) (← links)
- Neonatal management and outcome in alloimmune hemolytic disease (Q33441829) (← links)
- Trace elements of the micropremie (Q33847849) (← links)
- Iron status and the treatment of the anemia of prematurity (Q34777475) (← links)
- The Impact of Neonatal Illness on Nutritional Requirements-One Size Does Not Fit All (Q35111707) (← links)
- Postdischarge Iron Requirements of the Preterm Infant (Q36063410) (← links)
- Is supplementary iron useful when preterm infants are treated with erythropoietin? (Q36659945) (← links)
- Iron therapy for preterm infants. (Q37134035) (← links)
- Effects of early parenteral iron combined erythropoietin in preterm infants: A randomized controlled trial (Q41918130) (← links)
- Early erythropoiesis-stimulating agents in preterm or low birth weight infants (Q47176323) (← links)
- [Recombinant human erythropoietin in premature infants. Evaluation of a one year experience] (Q73077332) (← links)
- Early erythropoiesis-stimulating agents in preterm or low birth weight infants (Q89672648) (← links)